Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors

INTRODUCTION: Trophoblast cell surface antigen 2 (TROP2) is the target of sacituzumab govitecan, an antibody-drug conjugate approved for treatment of triple negative breast cancer and urothelial carcinoma. METHODS: A tissue microarray containing 18,563 samples from 150 different tumor types and subt...

Descripción completa

Detalles Bibliográficos
Autores principales: Dum, David, Taherpour, Noushin, Menz, Anne, Höflmayer, Doris, Völkel, Cosima, Hinsch, Andrea, Gorbokon, Natalia, Lennartz, Maximilian, Hube-Magg, Claudia, Fraune, Christoph, Bernreuther, Christian, Lebok, Patrick, Clauditz, Till S., Jacobsen, Frank, Sauter, Guido, Uhlig, Ria, Wilczak, Waldemar, Steurer, Stefan, Minner, Sarah, Marx, Andreas H., Simon, Ronald, Burandt, Eike, Krech, Till, Luebke, Andreas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393818/
https://www.ncbi.nlm.nih.gov/pubmed/35477165
http://dx.doi.org/10.1159/000522206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393818/
https://www.ncbi.nlm.nih.gov/pubmed/35477165
http://dx.doi.org/10.1159/000522206

Ejemplares similares